Softwr

Research · head to head

Dotmatics vs Schrodinger

Dotmatics logo

Dotmatics

Research

Research informatics group behind GraphPad Prism, SnapGene, Geneious and LabArchives, now owned by Siemens

From
On request
Rated
-
Full reviewWebsite
Schrodinger logo

Schrodinger

Research

Physics based molecular modelling and drug discovery software, licensed by token pool

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Dotmatics the portfolio was assembled by acquisition and integration between the constituent products is uneven, so buying several Dotmatics brands does not deliver a single connected environment and often means the same manual export steps as before.; Schrodinger licences are sold as token pools rather than unlimited module access, so a department can be blocked mid campaign because colleagues are consuming concurrency, and expanding the pool is a new commercial negotiation rather than a setting.
  • They diverge on capability: Dotmatics covers Dotmatics platform, Schrodinger covers Maestro.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which Dotmatics and Schrodinger actually diverge.

Attributes where Dotmatics and Schrodinger differ
AttributeDotmaticsSchrodinger
PlatformsWeb, Windows, macOS, On-premiseLinux, macOS, Windows, Web

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Research).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Dotmatics

  • Dotmatics platform
  • GraphPad Prism
  • SnapGene
  • Geneious Prime and Biologics
  • LabArchives
  • Flow cytometry tools
  • Protein Metrics
  • Siemens ownership

Only in Schrodinger

  • Maestro
  • Glide
  • FEP+
  • Desmond
  • Jaguar
  • LiveDesign
  • Materials Science suite

What people use each for

The jobs each tool is most often brought in to do.

Dotmatics

  • A pharmaceutical company consolidating compound registration, assay data and biology screening onto one informatics layernot Schrodinger
  • A biotech that already owns Prism, SnapGene and Geneious separately and wants to understand what a group contract would covernot Schrodinger
  • A university licensing LabArchives across departments as an institutional electronic lab notebooknot Schrodinger
  • A biologics group needing sequence analysis, flow cytometry and proteomics tools from one supplier with a single procurement routenot Schrodinger

Schrodinger

  • A medicinal chemistry programme using FEP+ to prioritise which analogues to synthesise, where avoiding a handful of wasted syntheses pays for the licencenot Dotmatics
  • A structure based design campaign that needs docking at scale against a target with a good crystal structurenot Dotmatics
  • A materials group modelling polymer or electrolyte properties before committing to formulation experimentsnot Dotmatics
  • A university modelling group that qualifies for the published academic site licence and needs Maestro across a teaching and research cohortnot Dotmatics

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Dotmatics

  • The portfolio was assembled by acquisition and integration between the constituent products is uneven, so buying several Dotmatics brands does not deliver a single connected environment and often means the same manual export steps as before.
  • The Siemens acquisition completed in July 2025 with stated revenue synergy targets, which usually translates into pressure to move individually bought desktop licences into larger platform agreements, and small buyers of a single Prism or SnapGene seat should expect that pressure at renewal.
  • Nothing about the enterprise platform is publicly priced, and even the individual applications are increasingly moved to subscription, so total cost across a research group is hard to establish before negotiation.
  • Each acquired product retains its own licence terms, support channel and release cycle, so an organisation using four Dotmatics brands manages four different renewal dates, entitlement models and support experiences.
  • Enterprise deployments require data migration and configuration services, and validated instances for regulated use add both cost and an ongoing customer revalidation duty after each release, so the informatics platform is a programme rather than a purchase.

Schrodinger

  • Licences are sold as token pools rather than unlimited module access, so a department can be blocked mid campaign because colleagues are consuming concurrency, and expanding the pool is a new commercial negotiation rather than a setting.
  • Commercial pricing is not published and is negotiated against modules, cores and term, so two companies of similar size can pay very different amounts and neither can benchmark the other.
  • FEP+ needs substantial GPU capacity that is not included in the licence, so the real annual cost includes cloud or on premise hardware that often rivals the software line item.
  • The tools require trained computational chemists to produce trustworthy results, and an organisation without that function will generate predictions it cannot interpret or defend to its own medicinal chemists.
  • Schrodinger runs its own internal drug discovery pipeline alongside selling software to discovery companies, and some prospective customers treat that dual role as a conflict when discussing proprietary targets, which slows procurement even where contractual separation exists.

Pricing, plan by plan

Dotmatics

On request
  • Dotmatics platform$undefined/year
    • Enterprise informatics platform priced per user per year on quotation
    • Chemistry and biology registration, assay data and ELN modules scoped separately
    • Implementation and data migration services quoted as a separate programme

Schrodinger

On request
  • Commercial licence$undefined/year
    • Quoted per customer against modules, cores and licence term
    • Applications draw from a shared token pool that caps concurrency
    • GPU compute for FEP+ and Desmond is a separate cost, on premise or cloud
  • Academic site licence$undefined/year
    • Published academic entry around 7,500 USD a year for a premium package with a token allocation
    • Restricted to academic and research use, not work supporting a commercial enterprise
    • Maestro generally unrestricted with tokens shared for compute heavy applications

Which should you pick?

Choose Dotmatics if

  • You need dotmatics platform.
  • You work on Web, Windows, macOS, On-premise.
  • You also want graphpad prism.
Dotmatics review

Choose Schrodinger if

  • You need maestro.
  • You work on Linux, macOS, Windows, Web.
  • You also want glide.
Schrodinger review

Questions people ask

Is Dotmatics or Schrodinger better?
Neither clearly leads. Dotmatics starts at On request and Schrodinger at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Dotmatics or Schrodinger?
Dotmatics starts at On request and Schrodinger at On request.
Does Dotmatics or Schrodinger run on more platforms?
Dotmatics runs on Web, Windows, macOS, On-premise. Schrodinger runs on Linux, macOS, Windows, Web.
What is Dotmatics best used for?
Dotmatics is most often used for a pharmaceutical company consolidating compound registration, assay data and biology screening onto one informatics layer, a biotech that already owns prism, snapgene and geneious separately and wants to understand what a group contract would cover, a university licensing labarchives across departments as an institutional electronic lab notebook, a biologics group needing sequence analysis, flow cytometry and proteomics tools from one supplier with a single procurement route. Of those, a pharmaceutical company consolidating compound registration, assay data and biology screening onto one informatics layer and a biotech that already owns prism, snapgene and geneious separately and wants to understand what a group contract would cover are not what Schrodinger is typically brought in for.
What can Dotmatics do that Schrodinger cannot?
Dotmatics covers Dotmatics platform, GraphPad Prism, SnapGene, Geneious Prime and Biologics. Schrodinger covers Maestro, Glide, FEP+, Desmond.

Answered from the vendors’ own pages

Dotmatics: Who owns Dotmatics?

Siemens, which completed a 5.1 billion dollar acquisition on 1 July 2025. Dotmatics now sits inside Siemens Digital Industries Software.

Schrodinger: How is Schrodinger software licensed?

Annual licences with a shared token pool. Tokens cap how much you can run at once rather than which modules you own outright.

Dotmatics: Is GraphPad Prism a Dotmatics product?

Yes. So are SnapGene, Geneious, LabArchives, FCS Express, OMIQ, Protein Metrics, SoftGenetics and nQuery.

Schrodinger: Is there published pricing?

Only for academic site licences, which start around 7,500 USD a year for a premium package. Commercial pricing is quoted.

Dotmatics: Do the products work together?

To varying degrees. They were acquired separately and integration across the portfolio is uneven, so verify the specific pair you care about before assuming it.

Schrodinger: Do I need my own GPUs?

For FEP+ and Desmond in practice yes, or cloud GPU capacity. Compute is not included in the licence.

Dotmatics: Is enterprise pricing published?

No. The informatics platform is quoted per user per year with modules and services scoped separately.

Schrodinger: Does Schrodinger compete with its customers?

It runs its own drug pipeline as well as selling software. It manages this through contractual separation, but buyers with sensitive targets should raise it during procurement.

Share

Related pages

More on Dotmatics

More on Schrodinger

Keep looking

Other head to heads